Literature DB >> 12667252

Lymphocyte subset numbers depend on the bacterial origin of sepsis.

M Holub1, Z Klucková, M Helcl, J Príhodov, R Rokyta, O Beran.   

Abstract

OBJECTIVE: To determine the quantitative variances in peripheral blood lymphocyte subsets during sepsis, and their clinical significance.
METHODS: Peripheral blood lymphocyte subsets were enumerated in 32 non-surgical septic patients during the first 14 days of hospitalization; results from septic patients were compared with those from 34 healthy controls. Influences of the severity and the bacterial etiology of sepsis on changes in lymphocyte subsets were also assessed.
RESULTS: Significant decreases (P < 0.05) from normal values of CD4+, CD8+ and total T-lymphocytes were observed in septic patients, but the decline persisted only for CD4+ T-lymphocytes and natural killer (NK) cells for 3 and 7 days, respectively. In addition, the numbers of CD3+/DR+ lymphocytes were significantly elevated on day 14. There were no correlations between these alterations and the severity of sepsis. Gram-positive sepsis (n = 10), which was mainly due to Streptococcus pneumoniae and Staphylococcus aureus, caused prolonged decreases in CD4+, CD8+ and total T-lymphocytes, and a reduction in NK cells, that lasted for >or=14 days. Conversely, patients with sepsis due to Gram-negative pathogens (Neisseria meningitidis, n = 8; enterobacteria, n = 2) achieved full recovery of the subsets within 3 days. Moreover, the patients with Gram-negative sepsis demonstrated a significant increase in B-lymphocytes, and a rise in the numbers of CD3+/DR+ and CD4+ T-lymphocytes, which were more rapid than in patients with Gram-positive sepsis.
CONCLUSION: Our results indicate that Gram-positive sepsis causes stronger suppression of peripheral blood lymphocyte subsets in comparison to sepsis due to Gram-negative pathogens.

Entities:  

Mesh:

Year:  2003        PMID: 12667252     DOI: 10.1046/j.1469-0691.2003.00518.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  27 in total

1.  Effects of murine endotoxemia on lymphocyte subsets and clearance of staphylococcal pulmonary infection.

Authors:  M Holub; D A Lawrence; T K Mondal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 2.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

3.  Microdialysis-assessed interstitium alterations during sepsis: relationship to stage, infection, and pathogen.

Authors:  Petros Kopterides; Nikitas Nikitas; Dimitra Vassiliadi; Stylianos E Orfanos; Maria Theodorakopoulou; Ioannis Ilias; Eleni Boutati; George Dimitriadis; Eirini Maratou; Argyris Diamantakis; Apostolos Armaganidis; Urban Ungerstedt; Ioanna Dimopoulou
Journal:  Intensive Care Med       Date:  2011-08-17       Impact factor: 17.440

4.  Multifactorial relationships between intramammary invasion by Staphylococcus aureus and bovine leukocyte markers.

Authors:  Ariel L Rivas; Steven J Schwager; Rubén N González; Fred W Quimby; Kevin L Anderson
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

5.  Effects of anti-inflammatory vagus nerve stimulation in endotoxemic rats on blood and spleen lymphocyte subsets.

Authors:  S Mihaylova; H Schweighöfer; H Hackstein; B Rosengarten
Journal:  Inflamm Res       Date:  2014-05-07       Impact factor: 4.575

6.  Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection.

Authors:  Charalambos Gogos; Antigone Kotsaki; Aimilia Pelekanou; George Giannikopoulos; Ilia Vaki; Panagiota Maravitsa; Stephanos Adamis; Zoi Alexiou; George Andrianopoulos; Anastasia Antonopoulou; Sofia Athanassia; Fotini Baziaka; Aikaterini Charalambous; Sofia Christodoulou; Ioanna Dimopoulou; Ioannis Floros; Efthymia Giannitsioti; Panagiotis Gkanas; Aikaterini Ioakeimidou; Kyriaki Kanellakopoulou; Niki Karabela; Vassiliki Karagianni; Ioannis Katsarolis; Georgia Kontopithari; Petros Kopterides; Ioannis Koutelidakis; Pantelis Koutoukas; Hariklia Kranidioti; Michalis Lignos; Konstantinos Louis; Korina Lymberopoulou; Efstratios Mainas; Androniki Marioli; Charalambos Massouras; Irini Mavrou; Margarita Mpalla; Martha Michalia; Heleni Mylona; Vassilios Mytas; Ilias Papanikolaou; Konstantinos Papanikolaou; Maria Patrani; Ioannis Perdios; Diamantis Plachouras; Aikaterini Pistiki; Konstantinos Protopapas; Kalliopi Rigaki; Vissaria Sakka; Monika Sartzi; Vassilios Skouras; Maria Souli; Aikaterini Spyridaki; Ioannis Strouvalis; Thomas Tsaganos; George Zografos; Konstantinos Mandragos; Phylis Klouva-Molyvdas; Nina Maggina; Helen Giamarellou; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  Crit Care       Date:  2010-05-26       Impact factor: 9.097

7.  Immune status in sepsis: the bug, the site of infection and the severity can make the difference.

Authors:  Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Crit Care       Date:  2010-06-18       Impact factor: 9.097

Review 8.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

9.  Leukocyte phenotyping to stratify septic shock patients.

Authors:  Jonathan E McDunn; Richard S Hotchkiss
Journal:  Crit Care       Date:  2009-04-03       Impact factor: 9.097

10.  Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients.

Authors:  Jorge Monserrat; Raul de Pablo; Eduardo Reyes; David Díaz; Hugo Barcenilla; Manuel R Zapata; Antonio De la Hera; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Crit Care       Date:  2009-02-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.